-
121
Supplementary Figure S12 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
122
Supplementary Figure S15 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
123
Figure 4 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
124
Supplementary Table S4 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
125
Supplementary Figure S6 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
126
Supplementary Figure S2 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
127
Figure 2 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
128
Supplementary Figure S14 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
129
Supplementary Data from Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
130
Supplementary Data S1 from Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor–Positive (HR+)/HER2-Negative Metastatic Breast Canc...
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
131
Figure 2 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
132
Figure 5 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
133
Supplementary Figure S10 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
134
Figure 5 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
135
Figure 3 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
136
Figure 1 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
137
Supplementary Figure S7 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
138
-
139
Supplementary Figure S1 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”
-
140
Figure 2 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
प्रकाशित 2025विषय: “…Cancer Detection and Diagnosis…”